Benjamin Weinberg, Associate Professor Of Medicine at Georgetown Lombardi Comprehensive Cancer Center, shared an article he and colleagues authored on X:
“Paper is out!!! FDA approved for NRG1 Fusion+ Non-Small Cell Lung Cancer and Pancreatic Cancer
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer.”
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
Authors: Alison M. Schram et al.
